Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519

Combining fluorescence R-banding, fluorescence in situ hybridization and spectral karyotyping allowed us to precisely define chromosomal breakpoints, gains, losses and a newly detected amplification in the human mantle cell lymphoma (MCL) cell line GRANTA-519. GRANTA-519 is characterized by the t(11...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer genetics and cytogenetics 2004-09, Vol.153 (2), p.144-150
Hauptverfasser: Rudolph, C., Steinemann, D., von Neuhoff, N., Gadzicki, D., Ripperger, T., Drexler, H.G., Mrasek, K., Liehr, T., Claussen, U., Emura, M., Schrock, E., Schlegelberger, B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 150
container_issue 2
container_start_page 144
container_title Cancer genetics and cytogenetics
container_volume 153
creator Rudolph, C.
Steinemann, D.
von Neuhoff, N.
Gadzicki, D.
Ripperger, T.
Drexler, H.G.
Mrasek, K.
Liehr, T.
Claussen, U.
Emura, M.
Schrock, E.
Schlegelberger, B.
description Combining fluorescence R-banding, fluorescence in situ hybridization and spectral karyotyping allowed us to precisely define chromosomal breakpoints, gains, losses and a newly detected amplification in the human mantle cell lymphoma (MCL) cell line GRANTA-519. GRANTA-519 is characterized by the t(11;14)(q13;q32) resulting in overexpression of cyclin D1, a key player in cell cycle control. Hitherto unresolved complex rearrangements involve 1p, 1q, 3cen, 9p, 11q, 12p, 12q, 16p, 17p, and 18cen. Moreover, a 4- to 6-fold gain of sequences on 18q leads to a low-level amplification of the BCL2 gene and to an overexpression of the BCL2 protein. These results provide the basis for the identification of not only candidate oncogenes responsible for MCL in gained regions, but also for the identification of putative tumor suppressor genes in commonly deleted regions like 1p22, which would eventually enable functional studies of these genes.
doi_str_mv 10.1016/j.cancergencyto.2004.01.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66850703</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165460804000251</els_id><sourcerecordid>19740451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-f1fdb59d8e37ad2a1b88515066156989644a40f6c3306d761382d897522e24c33</originalsourceid><addsrcrecordid>eNqNkUFr3DAQhUVpSbZp_kIxFHqzO2NLskxPS0iTQtJCSOhRaOVxV4ttbSVtYfvro2UXSk_NaZjhmzfDe4x9QKgQUH7aVNbMlsJPmu0--aoG4BVgBSBfsQWqtik5F_I1W2RalFyCOmdvY9wAQFt38oydo2gENMAX7Me9H8nuRhOKg1jWpORsYdcmGJsouD8mOT8XfijSmorJzGmkwtI4FuN-2q79ZE6dm6m4eVh-e1yWArt37M1gxkiXp3rBnr5cP17dlnffb75eLe9KyxFSOeDQr0TXK2pa09cGV0oJFCAlCtmpTnJuOAzSNg3IvpXYqLpXXSvqmmqepxfs41F3G_yvHcWkJxcPD5mZ_C5qKZWAFv4PYtdy4AIz-PkI2uBjDDTobXCTCXuNoA8B6I3-JwB9CEAD6hxA3n5_OrNbTdT_3T05noHrI0DZld-Ogo7WZSHqXSCbdO_diw49AxsXnSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19740451</pqid></control><display><type>article</type><title>Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Rudolph, C. ; Steinemann, D. ; von Neuhoff, N. ; Gadzicki, D. ; Ripperger, T. ; Drexler, H.G. ; Mrasek, K. ; Liehr, T. ; Claussen, U. ; Emura, M. ; Schrock, E. ; Schlegelberger, B.</creator><creatorcontrib>Rudolph, C. ; Steinemann, D. ; von Neuhoff, N. ; Gadzicki, D. ; Ripperger, T. ; Drexler, H.G. ; Mrasek, K. ; Liehr, T. ; Claussen, U. ; Emura, M. ; Schrock, E. ; Schlegelberger, B.</creatorcontrib><description>Combining fluorescence R-banding, fluorescence in situ hybridization and spectral karyotyping allowed us to precisely define chromosomal breakpoints, gains, losses and a newly detected amplification in the human mantle cell lymphoma (MCL) cell line GRANTA-519. GRANTA-519 is characterized by the t(11;14)(q13;q32) resulting in overexpression of cyclin D1, a key player in cell cycle control. Hitherto unresolved complex rearrangements involve 1p, 1q, 3cen, 9p, 11q, 12p, 12q, 16p, 17p, and 18cen. Moreover, a 4- to 6-fold gain of sequences on 18q leads to a low-level amplification of the BCL2 gene and to an overexpression of the BCL2 protein. These results provide the basis for the identification of not only candidate oncogenes responsible for MCL in gained regions, but also for the identification of putative tumor suppressor genes in commonly deleted regions like 1p22, which would eventually enable functional studies of these genes.</description><identifier>ISSN: 0165-4608</identifier><identifier>EISSN: 1873-4456</identifier><identifier>DOI: 10.1016/j.cancergencyto.2004.01.006</identifier><identifier>PMID: 15350304</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cell Culture Techniques - methods ; Cell Line, Tumor ; Chromosome Banding ; Chromosome Mapping ; Cytogenetics ; Humans ; In Situ Hybridization, Fluorescence ; Karyotyping ; Lymphoma, Mantle-Cell - genetics ; Lymphoma, Mantle-Cell - pathology ; Metaphase ; Translocation, Genetic - genetics</subject><ispartof>Cancer genetics and cytogenetics, 2004-09, Vol.153 (2), p.144-150</ispartof><rights>2004 Elsevier Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-f1fdb59d8e37ad2a1b88515066156989644a40f6c3306d761382d897522e24c33</citedby><cites>FETCH-LOGICAL-c410t-f1fdb59d8e37ad2a1b88515066156989644a40f6c3306d761382d897522e24c33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0165460804000251$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15350304$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rudolph, C.</creatorcontrib><creatorcontrib>Steinemann, D.</creatorcontrib><creatorcontrib>von Neuhoff, N.</creatorcontrib><creatorcontrib>Gadzicki, D.</creatorcontrib><creatorcontrib>Ripperger, T.</creatorcontrib><creatorcontrib>Drexler, H.G.</creatorcontrib><creatorcontrib>Mrasek, K.</creatorcontrib><creatorcontrib>Liehr, T.</creatorcontrib><creatorcontrib>Claussen, U.</creatorcontrib><creatorcontrib>Emura, M.</creatorcontrib><creatorcontrib>Schrock, E.</creatorcontrib><creatorcontrib>Schlegelberger, B.</creatorcontrib><title>Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519</title><title>Cancer genetics and cytogenetics</title><addtitle>Cancer Genet Cytogenet</addtitle><description>Combining fluorescence R-banding, fluorescence in situ hybridization and spectral karyotyping allowed us to precisely define chromosomal breakpoints, gains, losses and a newly detected amplification in the human mantle cell lymphoma (MCL) cell line GRANTA-519. GRANTA-519 is characterized by the t(11;14)(q13;q32) resulting in overexpression of cyclin D1, a key player in cell cycle control. Hitherto unresolved complex rearrangements involve 1p, 1q, 3cen, 9p, 11q, 12p, 12q, 16p, 17p, and 18cen. Moreover, a 4- to 6-fold gain of sequences on 18q leads to a low-level amplification of the BCL2 gene and to an overexpression of the BCL2 protein. These results provide the basis for the identification of not only candidate oncogenes responsible for MCL in gained regions, but also for the identification of putative tumor suppressor genes in commonly deleted regions like 1p22, which would eventually enable functional studies of these genes.</description><subject>Cell Culture Techniques - methods</subject><subject>Cell Line, Tumor</subject><subject>Chromosome Banding</subject><subject>Chromosome Mapping</subject><subject>Cytogenetics</subject><subject>Humans</subject><subject>In Situ Hybridization, Fluorescence</subject><subject>Karyotyping</subject><subject>Lymphoma, Mantle-Cell - genetics</subject><subject>Lymphoma, Mantle-Cell - pathology</subject><subject>Metaphase</subject><subject>Translocation, Genetic - genetics</subject><issn>0165-4608</issn><issn>1873-4456</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFr3DAQhUVpSbZp_kIxFHqzO2NLskxPS0iTQtJCSOhRaOVxV4ttbSVtYfvro2UXSk_NaZjhmzfDe4x9QKgQUH7aVNbMlsJPmu0--aoG4BVgBSBfsQWqtik5F_I1W2RalFyCOmdvY9wAQFt38oydo2gENMAX7Me9H8nuRhOKg1jWpORsYdcmGJsouD8mOT8XfijSmorJzGmkwtI4FuN-2q79ZE6dm6m4eVh-e1yWArt37M1gxkiXp3rBnr5cP17dlnffb75eLe9KyxFSOeDQr0TXK2pa09cGV0oJFCAlCtmpTnJuOAzSNg3IvpXYqLpXXSvqmmqepxfs41F3G_yvHcWkJxcPD5mZ_C5qKZWAFv4PYtdy4AIz-PkI2uBjDDTobXCTCXuNoA8B6I3-JwB9CEAD6hxA3n5_OrNbTdT_3T05noHrI0DZld-Ogo7WZSHqXSCbdO_diw49AxsXnSA</recordid><startdate>20040901</startdate><enddate>20040901</enddate><creator>Rudolph, C.</creator><creator>Steinemann, D.</creator><creator>von Neuhoff, N.</creator><creator>Gadzicki, D.</creator><creator>Ripperger, T.</creator><creator>Drexler, H.G.</creator><creator>Mrasek, K.</creator><creator>Liehr, T.</creator><creator>Claussen, U.</creator><creator>Emura, M.</creator><creator>Schrock, E.</creator><creator>Schlegelberger, B.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20040901</creationdate><title>Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519</title><author>Rudolph, C. ; Steinemann, D. ; von Neuhoff, N. ; Gadzicki, D. ; Ripperger, T. ; Drexler, H.G. ; Mrasek, K. ; Liehr, T. ; Claussen, U. ; Emura, M. ; Schrock, E. ; Schlegelberger, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-f1fdb59d8e37ad2a1b88515066156989644a40f6c3306d761382d897522e24c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Cell Culture Techniques - methods</topic><topic>Cell Line, Tumor</topic><topic>Chromosome Banding</topic><topic>Chromosome Mapping</topic><topic>Cytogenetics</topic><topic>Humans</topic><topic>In Situ Hybridization, Fluorescence</topic><topic>Karyotyping</topic><topic>Lymphoma, Mantle-Cell - genetics</topic><topic>Lymphoma, Mantle-Cell - pathology</topic><topic>Metaphase</topic><topic>Translocation, Genetic - genetics</topic><toplevel>online_resources</toplevel><creatorcontrib>Rudolph, C.</creatorcontrib><creatorcontrib>Steinemann, D.</creatorcontrib><creatorcontrib>von Neuhoff, N.</creatorcontrib><creatorcontrib>Gadzicki, D.</creatorcontrib><creatorcontrib>Ripperger, T.</creatorcontrib><creatorcontrib>Drexler, H.G.</creatorcontrib><creatorcontrib>Mrasek, K.</creatorcontrib><creatorcontrib>Liehr, T.</creatorcontrib><creatorcontrib>Claussen, U.</creatorcontrib><creatorcontrib>Emura, M.</creatorcontrib><creatorcontrib>Schrock, E.</creatorcontrib><creatorcontrib>Schlegelberger, B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer genetics and cytogenetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rudolph, C.</au><au>Steinemann, D.</au><au>von Neuhoff, N.</au><au>Gadzicki, D.</au><au>Ripperger, T.</au><au>Drexler, H.G.</au><au>Mrasek, K.</au><au>Liehr, T.</au><au>Claussen, U.</au><au>Emura, M.</au><au>Schrock, E.</au><au>Schlegelberger, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519</atitle><jtitle>Cancer genetics and cytogenetics</jtitle><addtitle>Cancer Genet Cytogenet</addtitle><date>2004-09-01</date><risdate>2004</risdate><volume>153</volume><issue>2</issue><spage>144</spage><epage>150</epage><pages>144-150</pages><issn>0165-4608</issn><eissn>1873-4456</eissn><abstract>Combining fluorescence R-banding, fluorescence in situ hybridization and spectral karyotyping allowed us to precisely define chromosomal breakpoints, gains, losses and a newly detected amplification in the human mantle cell lymphoma (MCL) cell line GRANTA-519. GRANTA-519 is characterized by the t(11;14)(q13;q32) resulting in overexpression of cyclin D1, a key player in cell cycle control. Hitherto unresolved complex rearrangements involve 1p, 1q, 3cen, 9p, 11q, 12p, 12q, 16p, 17p, and 18cen. Moreover, a 4- to 6-fold gain of sequences on 18q leads to a low-level amplification of the BCL2 gene and to an overexpression of the BCL2 protein. These results provide the basis for the identification of not only candidate oncogenes responsible for MCL in gained regions, but also for the identification of putative tumor suppressor genes in commonly deleted regions like 1p22, which would eventually enable functional studies of these genes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15350304</pmid><doi>10.1016/j.cancergencyto.2004.01.006</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-4608
ispartof Cancer genetics and cytogenetics, 2004-09, Vol.153 (2), p.144-150
issn 0165-4608
1873-4456
language eng
recordid cdi_proquest_miscellaneous_66850703
source MEDLINE; Elsevier ScienceDirect Journals
subjects Cell Culture Techniques - methods
Cell Line, Tumor
Chromosome Banding
Chromosome Mapping
Cytogenetics
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Lymphoma, Mantle-Cell - genetics
Lymphoma, Mantle-Cell - pathology
Metaphase
Translocation, Genetic - genetics
title Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T18%3A38%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20cytogenetic%20characterization%20of%20the%20mantle%20cell%20lymphoma%20cell%20line%20GRANTA-519&rft.jtitle=Cancer%20genetics%20and%20cytogenetics&rft.au=Rudolph,%20C.&rft.date=2004-09-01&rft.volume=153&rft.issue=2&rft.spage=144&rft.epage=150&rft.pages=144-150&rft.issn=0165-4608&rft.eissn=1873-4456&rft_id=info:doi/10.1016/j.cancergencyto.2004.01.006&rft_dat=%3Cproquest_cross%3E19740451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19740451&rft_id=info:pmid/15350304&rft_els_id=S0165460804000251&rfr_iscdi=true